Toggle navigation
Publications
Researchers
Institutions
0
Sign In
Federated Authentication
(Click on the image)
Local Sign In
Password Recovery
Register
Sign In
João Pedro Melo Marques Pinho Ferreira
AuthID:
R-00J-GPJ
Publications
Confirmed
To Validate
Document Source:
All
Document Type:
All Document Types
Article (290)
Editorial Material (15)
Letter (15)
Review (11)
Article in Press (8)
Unpublished (4)
Abstract (3)
Correction (1)
Note (1)
Biographical-Item (1)
Year Start - End:
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
-
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Order:
Year Dsc
Year Asc
Cit. WOS Dsc
IF WOS Dsc
Cit. Scopus Dsc
IF Scopus Dsc
Title Asc
Title Dsc
Results:
10
20
30
40
50
Confirmed Publications: 349
101
TITLE:
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Full Text
AUTHORS:
Anker, Stefan D.; Butler, Javed; Usman, Muhammad Shariq; Filippatos, Gerasimos;
Ferreira, Joao Pedro
; Bocchi, Edimar; Bohm, Michael; Brunner La Rocca, Hans Pieter; Choi, Dong Ju; Chopra, Vijay; Chuquiure, Eduardo; Giannetti, Nadia; Gomez Mesa, Juan Esteban; Janssens, Stefan; Januzzi, James L.; Gonzalez Juanatey, Jose R.; Merkely, Bela; Nicholls, Stephen J.; Perrone, Sergio V.; Pina, Ileana L.;
Ponikowski, Piotr;
Senni, Michele;
Sim, David;
Spinar, Jindrich;
Squire, Iain;
Taddei, Stefano;
Tsutsui, Hiroyuki;
Verma, Subodh;
Vinereanu, Dragos;
Zhang, Jian;
Iwata, Tomoko;
Schnee, Janet M.;
Brueckmann, Martina;
Pocock, Stuart J.;
Zannad, Faiez;
...More
PUBLISHED:
2022
,
SOURCE:
NATURE MEDICINE,
VOLUME:
28,
ISSUE:
12
INDEXED IN:
Scopus
WOS
CrossRef
:
9
IN MY:
ORCID
|
CIÊNCIAVITAE
102
TITLE:
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
AUTHORS:
Balasubramanian, Priyadarshini; Wanner, Christoph;
Ferreira, Joao Pedro
; Ofstad, Anne Pernille; Elsaesser, Amelie; Zinman, Bernard;
Inzucchi, Silvio E.
;
PUBLISHED:
2022
,
SOURCE:
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
VOLUME:
107,
ISSUE:
7
INDEXED IN:
WOS
CrossRef
:
19
IN MY:
ORCID
|
CIÊNCIAVITAE
103
TITLE:
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
AUTHORS:
Ferreira, Joao Pedro
; Zannad, Faiez; Butler, Javed; Filipattos, Gerasimos; Ritter, Ivana; Schuler, Elke; Kraus, Bettina J.; Pocock, Stuart J.; Anker, Stefan D.; Packer, Milton;
PUBLISHED:
2022
,
SOURCE:
EUROPEAN HEART JOURNAL,
VOLUME:
43,
ISSUE:
31
INDEXED IN:
Scopus
WOS
CrossRef
:
42
IN MY:
ORCID
104
TITLE:
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
Full Text
AUTHORS:
Ferreira, JP
; Inzucchi, SE; Mattheus, M; Meinicke, T; Steubl, D; Wanner, C; Zinman, B;
PUBLISHED:
2022
,
SOURCE:
DIABETES OBESITY & METABOLISM,
VOLUME:
24,
ISSUE:
1
INDEXED IN:
Scopus
WOS
CrossRef
:
36
IN MY:
ORCID
|
CIÊNCIAVITAE
105
TITLE:
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
AUTHORS:
Filippatos, Gerasimos; Butler, Javed; Farmakis, Dimitrios; Zannad, Faiez; Ofstad, Anne Pernille;
Ferreira, Joao Pedro
; Green, Jennifer B.; Rosenstock, Julio; Schnaidt, Sven; Brueckmann, Martina; Pocock, Stuart J.;
Packer, Milton
;
Anker, Stefan D.
;
PUBLISHED:
2022
,
SOURCE:
CIRCULATION,
VOLUME:
146,
ISSUE:
9
INDEXED IN:
Scopus
WOS
CrossRef
:
60
IN MY:
ORCID
|
CIÊNCIAVITAE
106
TITLE:
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
Full Text
AUTHORS:
Michael Böhm; Javed Butler; Gerasimos Filippatos;
João Pedro Ferreira
; Stuart J Pocock; Amr Abdin; Felix Mahfoud; Martina Brueckmann; Nicholas D Gollop; Tomoko Iwata; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer; Stefan D Anker;
PUBLISHED:
2022
,
SOURCE:
Journal of the American College of Cardiology,
VOLUME:
80,
ISSUE:
1
INDEXED IN:
CrossRef
:
28
IN MY:
ORCID
|
CIÊNCIAVITAE
107
TITLE:
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
AUTHORS:
Subodh Verma; Nitish K Dhingra; Javed Butler;
Stefan D Anker
;
Joao Pedro Ferreira
; Gerasimos Filippatos;
James L Januzzi
;
Carolyn S P Lam
; Naveed Sattar; Barbara Peil;
Matias Nordaby
; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Milton Packer; Packer M.; Anker S.; Butler J.; Filippatos G.; Pocock S.;
Zannad F.;
Ferreira J.P.;
Brueckmann M.;
George J.;
Jamal W.;
Welty F.K.;
Palmer M.;
Clayton T.;
Parhofer K.G.
;
Pedersen T.R.;
Greenberg B.;
Konstam M.A.;
Lees K.R.;
Carson P.;
Doehner W.;
Miller A.;
Haas M.;
Pehrson S.;
Komajda M.;
Anand I.;
Teerlink J.;
Rabinstein A.;
Steiner T.;
Kamel H.;
Tsivgoulis G.;
Lewis J.;
Freston J.;
Kaplowitz N.
;
Mann J.;
Petrie J.;
Perrone S.;
Nicholls S.;
Janssens S.;
Bocchi E.;
Giannetti N.;
Verma S.;
Zhang J.;
Spinar J.;
Seronde M.F.;
Boehm M.;
Merkely B.;
Chopra V.;
Senni M.;
Taddi S.;
Tsutsui H.;
Choi D.J.;
Chuquiure E.;
La Rocca H.P.B.;
Ponikowski P.;
Juanatey J.R.G.;
Squire I.;
Januzzi J.;
Pina I.;
Bernstein R.;
Cheung A.;
Green J.;
Kaul S.;
Lam C.;
Lip G.;
Marx N.;
McCullough P.;
Mehta C.;
Rosenstock J.;
Sattar N.;
Scirica B.;
Shah S.;
Wanner C.;
Aizenberg D.;
Cartasegna L.;
Colombo Berra F.;
Colombo H.;
Fernandez Moutin M.;
Glenny J.;
Alvarez Lorio C.;
Anauch D.
;
Campos R.;
Facta A.;
Fernandez A.;
Ahuad Guerrero R.;
Lobo Márquez L.;
...More
PUBLISHED:
2022
,
SOURCE:
LANCET DIABETES & ENDOCRINOLOGY,
VOLUME:
10,
ISSUE:
1
INDEXED IN:
Scopus
WOS
CrossRef
:
32
IN MY:
ORCID
|
CIÊNCIAVITAE
108
TITLE:
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
AUTHORS:
Butler, Javed; Filippatos, Gerasimos; Siddiqi, Tariq Jamal; Brueckmann, Martina; Bohm, Michael; Chopra, Vijay K.;
Ferreira, Joao Pedro
;
Januzzi, James L.
; Kaul, Sanjay; Pina, Ileana L.; Ponikowski, Piotr; Shah, Sanjiv J.; Senni, Michele;
Vedin, Ola
; Verma, Subodh; Peil, Barbara; Pocock, Stuart J.; Zannad, Faiez;
Packer, Milton
;
Anker, Stefan D.
;
PUBLISHED:
2022
,
SOURCE:
CIRCULATION,
VOLUME:
145,
ISSUE:
3
INDEXED IN:
WOS
CrossRef
:
122
IN MY:
ORCID
|
CIÊNCIAVITAE
109
TITLE:
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
AUTHORS:
Michael Böhm; Stefan Anker; Felix Mahfoud; Lucas Lauder; Gerasimos Filippatos;
João Pedro Ferreira
; Stuart J Pocock; Martina Brueckmann; Ilias Saloustros; Elke Schüler; Christoph Wanner; Faiez Zannad; Milton Packer; Javed Butler;
PUBLISHED:
2022
,
SOURCE:
European Heart Journal,
VOLUME:
44,
ISSUE:
5
INDEXED IN:
CrossRef
:
21
IN MY:
ORCID
|
CIÊNCIAVITAE
110
TITLE:
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
AUTHORS:
Ferreira, Joao Pedro
;
Vasques Novoa, Francisco
; Ferrao, Diana;
Saraiva, Francisca
;
Falcao Pires, Ines
;
Neves, Joao Sergio
;
Sharma, Abhinav
; Rossignol, Patrick; Zannad, Faiez;
Leite Moreira, Adelino
;
PUBLISHED:
2022
,
SOURCE:
DIABETES CARE,
VOLUME:
45,
ISSUE:
7
INDEXED IN:
Scopus
WOS
CrossRef
:
15
IN MY:
ORCID
|
CIÊNCIAVITAE
Add to Marked List
Check All
Export
×
Publication Export Settings
BibTex
EndNote
APA
CSV
PDF
Export Preview
Print
×
Publication Print Settings
HTML
PDF
Print Preview
Page 11 of 35. Total results: 349.
<<
<
7
8
9
10
11
12
13
14
15
>
>>
×
Select Source
This publication has:
2 records from
ISI
2 records from
SCOPUS
2 records from
DBLP
2 records from
Unpaywall
2 records from
Openlibrary
2 records from
Handle
Please select which records must be used by Authenticus!
×
Preview Publications
© 2024 CRACS & Inesc TEC - All Rights Reserved
Privacy Policy
|
Terms of Service